263 completed, 21 unknown, 20 terminated, 15 recruiting. 342 Phase 2, 46 Phase 1, 31 Phase 3.
Follow Nose Diseases: new trials by email Literature Review of Nose Diseases trials Research Report on Nose Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer SX-682, DTX - Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | Recruiting | National Cancer Institute (NCI) | 120 | 2026-11-09 | 2026-11-04 |
| Effect of Vitamin C Administration on Intraoperative Bleeding in Patients Undergoing Sinusoscopy Ascorbic acid, Placebo - Chronic Rhinosinusitis, Intraoperative Bleeding | Phase 2 | Not yet recruiting | Assiut University | 78 | 2026-11-01 | 2026-10-08 |
| Study of CM512 Injection in Patients With Perennial Allergic Rhinitis on Background Therapy CM512, Placebo - Perennial Allergic Rhinitis (PAR) | Phase 2 | Not yet recruiting | Beijing Keymed Biosciences Co., Ltd. | 200 | 2026-10-01 | 2026-10-22 |
| Study of Stapokibart Injection in Adolescent Subjects With Seasonal Allergic Rhinitis (SAR) Stapokibart injection - Seasonal Allergic Rhinitis (SAR) | Phase 2 | Not yet recruiting | Chengdu Kangnuoxing Biopharma,Inc. | 15 | 2026-06-01 | 2026-06-01 |
| Study to Investigate the Efficacy and Safety of Apomivir® Apomivir®, Placebo - Influenza | Phase 2 | Not yet recruiting | Far East Bio-Tec Co., Ltd | 196 | 2026-05-31 | 2025-05-14 |
| Triamcinolone Nanocapsules After Endoscopic Nasal Surgery Triamcinolone Acetonide-Loaded Polymeric Nanocapsules, Normal Saline Nasal Irrigation - Chronic Rhinosinusitis (CRS), Nasal Polyps | Phase 2 | Recruiting | Deraya University | 50 | 2026-05-01 | 2026-07-27 |
| PollenVax Subcutaneous Immunotherapy for Mugwort Pollen-Induced Allergic Rhinitis Recombinant Artemisia vulgaris allergen Art v 1 with Montanide ISA-51 adjuvant, Montanide ISA-51 placebo emulsion - Rhinitis Allergic | Phase 2 | Recruiting | Kazakh National Agrarian University | 138 | 2026-05-01 | 2026-06-29 |
| A Study to Learn More About How Well Oxymetazoline HCl 0.05% Nasal Gel Works and How Safe It Is in Healthy Adults Oxymetazoline HCl 0.05% nasal gel, Placebo nasal gel - Nasal Congestion, Nasal Obstruction | Phase 2 | Completed | Bayer | 120 | 2026-04-20 | 2026-06-08 |
| Trial of JYB1904 Injection in Patients With Perennial Allergic Rhinitis JYB1904, Placebo+JYB1904 - Perennial Allergic Rhinitis | Phase 2 | Not yet recruiting | Jemincare | 135 | 2026-04-01 | 2026-03-09 |
| Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis TQH2722 injection - Seasonal Allergic Rhinitis | Phase 2 | Recruiting | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | 300 | 2026-03-19 | 2026-03-27 |
| A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Seasonal Allergic Rhinitis AK139, Placebo - Seasonal Allergic Rhinitis | Phase 2 | Not yet recruiting | Akeso | 111 | 2026-03-02 | 2026-02-27 |
| Environmental Exposure Unit Trial in Subjects With Ragweed-induced Allergic Rhinitis INI-2004, Placebo - Allergic Rhinitis Due to Allergens, Rhinitis Allergic | Phase 2 | Completed | Inimmune Corporation | 78 | 2026-01-19 | 2026-04-29 |
| Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants Oxymetazoline + Triamcinolone - Nasal Obstruction, Chronic Rhinitis | Phase 2 | Terminated | Washington University School of Medicine | 3 | 2025-11-10 | 2026-03-23 |
| A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure ALDP001 Nasal Spray, Placebo Nasal spray - Seasonal Allergic Rhinitis (SAR) | Phase 2 | Recruiting | Alixer Nexgen Therapeutics Limited | 164 | 2025-10-17 | 2025-10-22 |
| Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma ALUTARD SQ® Felis domesticus - Allergic Rhinitis, Allergic Asthma | Phase 1 / Phase 2 | Recruiting | University of Zurich | 36 | 2025-08-20 | 2026-03-16 |
| A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis SHR-1819 Injection, SHR-1819 Injection Placebo - Seasonal Allergic Rhinitis | Phase 2 | Completed | Guangdong Hengrui Pharmaceutical Co., Ltd | 108 | 2025-08-06 | 2026-08-27 |
| Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis TQC2938 injection, TQC2938 Placebo - Seasonal Allergic Rhinitis | Phase 2 | Completed | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 136 | 2025-07-31 | 2026-02-10 |
| M-Gard Particulate EW Efficacy Study on Seasonal Allergic Rhinitis M-Gard, Placebo - Allergic Rhinitis Due to Grass Pollens | Phase 2 | Completed | RDC Clinical Pty Ltd | 20 | 2025-06-27 | 2026-03-06 |
| Toripalimab With Chemotherapy for Sinus Cancer Toripalimab, Carboplatin, Docetaxel - Sinonasal Cancer, Paranasal Sinus Neoplasms | Phase 2 | Recruiting | Dana-Farber Cancer Institute | 20 | 2025-06-17 | 2026-08-31 |
| Study of Yupingfeng Powder Treating Allergic Rhinitis (AR) Chinese Herbal Medicine granules, Placebo - Allergic Rhinitis | Phase 2 / Phase 3 | Recruiting | Chinese University of Hong Kong | 140 | 2025-03-27 | 2026-07-27 |
Showing 20 of 342. Sign in to see all of them.
Rhinitis, Allergic (119) · Rhinitis, Allergic, Seasonal (106) · Rhinitis (44) · Hypersensitivity (40) · Asthma (31) · Nasal Polyps (27) · Epistaxis (20) · Sinusitis (20) · Rhinitis, Allergic, Perennial (19) · Nasal Obstruction (16) · Telangiectasia, Hereditary Hemorrhagic (16) · Paranasal Sinus Neoplasms (13) · Dust Mite Allergy (12) · Rhinosinusitis (10) · Conjunctivitis, Allergic (9)
Otorhinolaryngologic Diseases (340) · Respiratory Tract Diseases (340) · Immune System Diseases (239) · Hypersensitivity, Immediate (232) · Respiratory Hypersensitivity (231) · Rhinitis (211) · Hypersensitivity (198) · Rhinitis, Allergic (105) · Infections (71) · Respiratory Tract Infections (70) · Pathological Conditions, Signs and Symptoms (66) · Paranasal Sinus Diseases (38) · Bronchial Diseases (36) · Lung Diseases (34)
Budesonide (11) · Cetirizine (8) · Mometasone Furoate (8) · Sodium Chloride (7) · Fluticasone (6) · azelastine (6) · dupilumab (6) · 6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide (5) · Loratadine (5) · Oxymetazoline (5) · Sublingual Immunotherapy (5) · Antigens, Dermatophagoides (4) · Beclomethasone (4) · Bevacizumab (4) · Cisplatin (4)
GlaxoSmithKline (25) · ALK-Abelló A/S (8) · Laboratorios Leti, S.L. (8) · HAL Allergy (7) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · Circassia Limited (6) · Merck Sharp & Dohme LLC (5) · AstraZeneca (4) · Bausch & Lomb Incorporated (4) · BioTech Tools S.A. (4) · Capnia, Inc. (4) · Faes Farma, S.A. (4) · Johns Hopkins University (4) · Karolinska Institutet (4) · Keymed Biosciences Co.Ltd (4)
United States (105) · Canada (49) · Germany (36) · China (29) · Spain (20) · Austria (16) · Sweden (15) · United Kingdom (15) · Belgium (12) · Poland (10) · France (9) · Taiwan (7) · Netherlands (6) · Switzerland (6) · Thailand (6)
Luo Zhang (7) · Lennart Greiff, MD, PhD (3) · Tim McNamara, PharmD (3) · Anish Bhatnagar, MD (2) · Bertil Andersson (2) · Charalampos Floudas, M.D. (2) · Claus Bachert, MD, PhD (2) · Deepen Patel, MD (2) · Dr Lynette Shek, Consultant (2)
PMID 24836393, PMID 33710614, PMID 19001265, PMID 24184147, PMID 25788949, PMID 26507708, PMID 31209698, PMID 34379802, PMID 39035788, PMID 12668793, PMID 14619332, PMID 14674933, PMID 15023840, PMID 15125017, PMID 15313870, PMID 15316237, PMID 15461603, PMID 15510034, PMID 15516669, PMID 15725047, PMID 15750716, PMID 15898976, PMID 16387596, PMID 16930249, PMID 17021320, PMID 17405780, PMID 17631952, PMID 17882910, PMID 17950857, PMID 18331513, PMID 18566548, PMID 18595980, PMID 18946234, PMID 19419611, PMID 19559969, PMID 19680119, PMID 19748656, PMID 19794023, PMID 19925886, PMID 19943178, PMID 19968632, PMID 20412135, PMID 20545698, PMID 20816182, PMID 20830768, PMID 20920778, PMID 21122901, PMID 21246519, PMID 21771118, PMID 21783242
2008 (4), 2009 (4), 2015 (4), 2019 (2), 2005 (1), 2014 (1), 2016 (1), 2023 (1), 2025 (1), P30CA042014 (1), R01HL084139 (1), U01AI123337 (1), U01AI158460 (1), U10CA180888 (1), U19AI095219 (1)